News

The findings from this trial are published in the Proceedings of the National Academy of Sciences. The disease, called X-linked severe combined immunodeficiency (XSCID), is caused by a

Under the terms of the agreement, Ista will pay Senju an upfront payment and aggregate development and approval milestones of approximately $6 million. The licensed drug is an

The company reached the agreement under the special protocol assessment process (SPA). The SPA process allows for FDA evaluation of a clinical trial protocol intended to form the

The phase II study in advanced non-small cell lung cancer (NSCLC) is a randomized trial that is expected to involve over 20 centers in the US and Europe

Keppra injection is an alternative for patients when oral administration is temporarily not feasible. It must be diluted prior to use and administered as a 15-minute intravenous infusion.

The open-label trial was conducted in Europe in collaboration with Aeterna Zentaris’ partner Spectrum Pharmaceuticals. Originally designed for 48 patients, the trial was extended to 64 patients where

XL647 is an orally bioavailable small molecule inhibitor of the HER2, EGF, VEGF and EphB4 receptor tyrosine kinases (RTKs). Although these individual RTKs are targets for currently approved

Chantix, the first new prescription aid to smoking cessation treatment approved by the FDA in nearly a decade, was approved in May 2006. According to the company, there

Dacogen was previously approved by the FDA in May 2006 for the treatment of patients with myelodysplastic syndromes (MDS), a group of blood disorders which may lead to